相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。PTH/PTHrP receptor expression on osteoblasts and osteocytes but not resorbing bone surfaces in growing rats
Beverley Fermor et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Bone histomorphometry: Standardization of nomenclature, symbols, and units: Report of the asbmr histomorphometry nomenclature committee
A. Michael Parfitt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
Targeted deletion of a distant transcriptional enhancer of the receptor activator of nuclear factor-kappa B ligand gene reduces bone remodeling and increases bone mass
Carlo Galli et al.
ENDOCRINOLOGY (2008)
Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength
Xiaodong Li et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2008)
Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin
Alexander G. Robling et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Age-related changes in trabecular architecture differ in female and male C57BL/6J mice
Vaida Glatt et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Minireview:: Targeting the Wnt/β-catenin pathway to regulate bone formation in the adult skeleton
Roland Baron et al.
ENDOCRINOLOGY (2007)
Molecular and cellular mechanisms of the anabolic effect of intermittent PTH
Robert L. Jilka
BONE (2007)
Minireview:: In vivo analysis of Wnt signaling in bone
Donald A. Glass et al.
ENDOCRINOLOGY (2007)
Targeted ablation of Osteocytes induces osteoporosis with defective mechanotransduction
Sawako Tatsumi et al.
CELL METABOLISM (2007)
DMP1-targeted Cre expression in odontoblasts and osteocytes
Y. Lu et al.
JOURNAL OF DENTAL RESEARCH (2007)
Serial analysis of chromatin occupancy identifies β-catenin target genes in colorectal carcinoma cells
Gregory S. Yochum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Induction of osteoblast differentiation by selective activation of kinase-mediated actions of the estrogen receptor
Stavroula Kousteni et al.
MOLECULAR AND CELLULAR BIOLOGY (2007)
Wnt but not BMP signaling is involved in the inhibitory action of sclerostin on BMP-stimulated bone formation
Rutger L. van Bezooijen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2007)
Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism
Jian Q. Feng et al.
NATURE GENETICS (2006)
Bone density ligand, sclerostin, directly interacts with LRP5 but not LRP5G171V to modulate Wnt activity
Debra L. Ellies et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Parathyroid hormone controls receptor activator of NF-κB ligand gene expression via a distant transcriptional enhancer
Qiang Fu et al.
MOLECULAR AND CELLULAR BIOLOGY (2006)
The Wnt co-receptor LRP5 is essential for skeletal mechanotransduction but not for the anabolic bone response to parathyroid hormone treatment
Kimihiko Sawakami et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Wnt proteins prevent apoptosis of both uncommitted osteoblast progenitors and differentiated osteoblasts by β-catenin-dependent and -independent signaling cascades involving Src/ERK and phosphatidylinositol 3-kinase/AKT
M Almeida et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Lrp5-independent activation of Wnt signaling by lithium chloride increases bone formation and bone mass in mice
P Clément-Lacroix et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Chronic elevation of parathyroid hormone in mice reduces expression of sclerostin by osteocytes: A novel mechanism for hormonal control of osteoblastogenesis
T Bellido et al.
ENDOCRINOLOGY (2005)
IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice
CA O'Brien et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Osteoblast-derived PTHrP is a potent endogenous bone anabolic agent that modifies the therapeutic efficacy of administered PTH 1-34
DS Miao et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
SOST is a target gene for PTH in bone
H Keller et al.
BONE (2005)
Stretch-induced PTH-related protein gene expression in osteoblasts
XS Chen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
SOST is a ligand for LRP5/LRP6 and a Wnt signaling inhibitor
M Semënov et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Ovariectomy-induced bone loss varies among inbred strains of mice
ML Bouxsein et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Genomic deletion of a long-range bone enhancer misregulates sclerostin in Van Buchem disease
GG Loots et al.
GENOME RESEARCH (2005)
Essential role of β-catenin in postnatal bone acquisition
SL Holmen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Dentin matrix protein 1 gene cis-regulation -: Use in osteocytes to characterize local responses to mechanical loading in vitro and in vivo
WC Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling
XF Li et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation
DA Glass et al.
DEVELOPMENTAL CELL (2005)
Dmp1-deficient mice display severe defects in cartilage formation responsible for a chondrodysplasia-like phenotype
L Ye et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength
CA O'Brien et al.
ENDOCRINOLOGY (2004)
Skeletal abnormalities in Pth-null mice are influenced by dietary calcium
DS Miao et al.
ENDOCRINOLOGY (2004)
Constitutively active PTH/PTHrP receptor in odontoblasts alters odontoblast and ameloblast function and maturation
LM Calvi et al.
MECHANISMS OF DEVELOPMENT (2004)
Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist
RL van Bezooijen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Parathyroid hormone-related peptide is required for increased trabecular bone volume in parathyroid hormone-null mice
DS Miao et al.
ENDOCRINOLOGY (2004)
Dentin matrix protein 1 expression during osteoblastic differentiation, generation of an osteocyte GFP-transgene
I Kalajzic et al.
BONE (2004)
The Wnt antagonist secreted frizzled-related protein-1 is a negative regulator of trabecular bone formation in adult mice
PVN Bodine et al.
MOLECULAR ENDOCRINOLOGY (2004)
Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts - A putative explanation for why intermittent administration is needed for bone anabolism
T Bellido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
In vivo administration of 1,25-dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH
Y Ueno et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2003)
High bone mass in mice expressing a mutant LRP5 gene
P Babij et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Osteocyte control of bone formation via sclerostin, a novel BMP antagonist
DG Winkler et al.
EMBO JOURNAL (2003)
Cbfa1-independent decrease in osteoblast proliferation, osteopenia, and persistent embryonic eye vascularization in mice deficient in Lrp5, a Wnt coreceptor
M Kato et al.
JOURNAL OF CELL BIOLOGY (2002)
Use of type I collagen green fluorescent protein transgenes to identify subpopulations of cells at different stages of the osteoblast lineage
I Kalajzic et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2002)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
YQ Gong et al.
CELL (2001)
naked cuticle targets dishevelled to antagonize Wnt signal transduction
R Rousset et al.
GENES & DEVELOPMENT (2001)
Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
ME Brunkow et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
W Balemans et al.
HUMAN MOLECULAR GENETICS (2001)
Activated parathyroid hormone/parathyroid hormone-related protein receptor in osteoblastic cells differentially affects cortical and trabecular bone
LM Calvi et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)